Form D · Biotechnology

Jennerex, Inc.

San Francisco, CA · CIK 0001525143

Offering snapshot reported Oct 13, 2011 · SEC filing

Reported sold
$1.75M
Offering amount: $1.75M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 9, 2011
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 13, 2011Initial$1,750,006No comparison1SEC filing
Aug 18, 2011Amendment$8,601,363$4,971,217vs Jul 11, 201174SEC filing
Jul 11, 2011Initial$3,630,146No comparison53SEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-167195

Source: Form D, filed Oct 13, 2011. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Dr. John C Bell Director
John Bell Director
Peter D Charbonneau Director
Helena Chaye Executive
Dr. Terry Hermiston Director
Hoyoung Huh Director
David Kirn Director, Executive
Lara Longpre Executive
Brennan R Mulcahy Director
Martin Murphy Director
Ken Newport Director, Executive
Gregory Schafer Executive
Barry Sherman Director
Daniel K Spiegelman Director
Dr. Hartley Stern Director
Ron Vered Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
450 Sansome Street 16 Th Floor
San Francisco, CA, 94111